Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R. Dreindl is active.

Publication


Featured researches published by R. Dreindl.


Zeitschrift Fur Medizinische Physik | 2014

Radiochromic film dosimetry: Considerations on precision and accuracy for EBT2 and EBT3 type films

R. Dreindl; Dietmar Georg; M. Stock

Gafchromic® EBT2 film is a widely used dosimetric tool for quality assurance in radiation therapy. In 2012 EBT3 was presented as a replacement for EBT2 films. The symmetric structure of EBT3 films to reduce face-up/down dependency as well as the inclusion of a matte film surface to frustrate Newton Ring artifacts present the most prominent improvements of EBT3 films. The aim of this study was to investigate the characteristics of EBT3 films, to benchmark the films against the known EBT2-features and to evaluate the dosimetric behavior over a time period greater than 6 months. All films were irradiated to clinical photon beams (6 MV, 10 MV and 18 MV) on an Elekta Synergy Linac equipped with a Beam Modulator MLC in solid water phantom slabs. Film digitalization was done with a flatbed transparency scanner (Type Epson Expression 1680 Pro). MATLAB® was used for further statistical calculations and image processing. The investigations on post-irradiation darkening, film orientation, film uniformity and energy dependency resulted in negligible differences between EBT2 and EBT3 film. A minimal improvement in face-up/down dependence was found for EBT3. The matte film surface of EBT3 films turned out to be a practical feature as Newton rings could be eliminated completely. Considering long-term behavior (> 6 months) a shift of the calibration curve for EBT2 and EBT3 films due to changes in the dynamic response of the active component was observed. In conclusion, the new EBT3 film yields comparable results to its predecessor EBT2. The general advantages of radiochromic film dosimeters are completed by high film homogeneity, low energy dependence for the observed energy range and a minimized face-up/down dependence. EBT2 dosimetry-protocols can also be used for EBT3 films, but the inclusion of periodical recalibration-interval (e.g. once a quarter) is recommended for protocols of both film generations.


Radiotherapy and Oncology | 2015

Linking log files with dosimetric accuracy--A multi-institutional study on quality assurance of volumetric modulated arc therapy.

M. Pasler; J. Kaas; T. Perik; Job Geuze; R. Dreindl; Thomas Künzler; F.W. Wittkämper; Dietmar Georg

PURPOSE To systematically evaluate machine specific quality assurance (QA) for volumetric modulated arc therapy (VMAT) based on log files by applying a dynamic benchmark plan. METHODS AND MATERIALS A VMAT benchmark plan was created and tested on 18 Elekta linacs (13 MLCi or MLCi2, 5 Agility) at 4 different institutions. Linac log files were analyzed and a delivery robustness index was introduced. For dosimetric measurements an ionization chamber array was used. Relative dose deviations were assessed by mean gamma for each control point and compared to the log file evaluation. RESULTS Fourteen linacs delivered the VMAT benchmark plan, while 4 linacs failed by consistently terminating the delivery. The mean leaf error (±1SD) was 0.3±0.2 mm for all linacs. Large MLC maximum errors up to 6.5 mm were observed at reversal positions. Delivery robustness index accounting for MLC position correction (0.8-1.0) correlated with delivery time (80-128 s) and depended on dose rate performance. Dosimetric evaluation indicated in general accurate plan reproducibility with γ(mean)(±1 SD)=0.4±0.2 for 1 mm/1%. However single control point analysis revealed larger deviations and attributed well to log file analysis. CONCLUSION The designed benchmark plan helped identify linac related malfunctions in dynamic mode for VMAT. Log files serve as an important additional QA measure to understand and visualize dynamic linac parameters.


Physics in Medicine and Biology | 2018

Characteristic of EBT-XD and EBT3 radiochromic film dosimetry for photon and proton beams

Suphalak Khachonkham; R. Dreindl; G. Heilemann; Wolfgang Lechner; Hermann Fuchs; Hugo Palmans; Dietmar Georg; Peter Kuess

Recently, a new type of radiochromic film, the EBT-XD film, has been introduced for high dose radiotherapy. The EBT-XD film contains the same structure as the EBT3 film but has a slightly different composition and a thinner active layer. This study benchmarks the EBT-XD against EBT3 film for 6 MV and 10 MV photon beams, as well as for 97.4 MeV and 148.2 MeV proton beams and 15-100 kV x-rays. Dosimetric and film reading characteristics, such as post irradiation darkening, film orientation effect, lateral response artifact (LRA), film sensitivity, energy and beam quality dependency were investigated. Furthermore, quenching effects in the Bragg peak were investigated for a single proton beam energy for both film types, in addition measurements were performed in a spread-out Bragg peak. EBT-XD films showed the same characteristic on film darkening as EBT3. The effects between portrait and landscape orientation were reduced by 3.1% (in pixel value) for EBT-XD compared to EBT3 at a dose of 2000 cGy. The LRA is reduced for EBT-XD films for all investigated dose ranges. The sensitivity of EBT-XD films is superior to EBT3 for doses higher than 500 cGy. In addition, EBT-XD showed a similar dosimetric response for photon and proton irradiation with low energy and beam quality dependency. A quenching effect of 10% was found for both film types. The slight decrease in the thickness of the active layer and different composition configuration of EBT-XD resulted in a reduced film orientation effect and LRA, as well as a sensitivity increase in high-dose regions for both photon and proton beams. Overall, the EBT-XD film improved regarding film reading characteristics and showed advantages in the high-dose region for photon and proton beams.


Radiotherapy and Oncology | 2018

PO-0870: Characteristic of EBT-XD versus EBT3 radiochromic films for dosimetry in photon and proton beams

Peter Kuess; S. Khachonkham; R. Dreindl; G. Heilemann; Wolfgang Lechner; H. Fuchs; Dietmar Georg


Medical Physics | 2018

Implementation of dosimetry equipment and phantoms at the MedAustron light ion beam therapy facility

Loïc Grevillot; M. Stock; Hugo Palmans; Jhonnatan Osorio Moreno; Virgile Letellier; R. Dreindl; Alessio Elia; Hermann Fuchs; Antonio Carlino; Stanislav Vatnitsky


Radiotherapy and Oncology | 2017

EP-1556: Dosimetric commissioning of a TPS for a synchrotron-based proton PBS delivery system

Gabriele Kragl; T.T. Böhlen; A. Carlino; L. Grevillot; Hugo Palmans; A. Elia; B. Knäusl; J. Osorio; R. Dreindl; Johannes Hopfgartner; Stanislav Vatnitsky; M. Stock


Radiotherapy and Oncology | 2017

EP-1450: Implementation of dosimetry equipment and phantoms in clinical practice of light ion beam therapy

L. Grevillot; J. Osorio; V. Letellier; R. Dreindl; A. Elia; H. Fuchs; A. Carlino; Stanislav Vatnitsky; Hugo Palmans; M. Stock


Radiotherapy and Oncology | 2017

EP-1494: The MedAustron proton gantry: nozzle design recommendations based on Monte Carlo simulations

H. Fuchs; L. Grevillot; A. Elia; A. Carlino; J. Osorio; V. Letellier; R. Dreindl; M. Stock; Stanislav Vatnitsky


Radiotherapy and Oncology | 2017

PO-0800: Log file based performance characterization of a PBS dose delivery system with dose re-computation

T.T. Böhlen; R. Dreindl; J. Osorio; Gabriele Kragl; M. Stock


Radiotherapy and Oncology | 2015

OC-0249: A multi-institutional study on VMAT delivery accuracy and efficiency for a benchmark plan

M. Pasler; J. Kaas; T. Perik; J. Geuze; F.W. Wittkämper; R. Dreindl; T. Kuenzler; Dietmar Georg

Collaboration


Dive into the R. Dreindl's collaboration.

Top Co-Authors

Avatar

Dietmar Georg

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

M. Stock

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Hugo Palmans

National Physical Laboratory

View shared research outputs
Top Co-Authors

Avatar

Stanislav Vatnitsky

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

F.W. Wittkämper

Netherlands Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

J. Kaas

Netherlands Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

T. Perik

Netherlands Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

G. Heilemann

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Gabriele Kragl

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Hermann Fuchs

Medical University of Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge